Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Classical Hodgkin's Lymphoma”

236 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 236 results

Testing effectiveness (Phase 2)Study completedNCT00967369
What this trial is testing

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Classical Hodgkin Lymphoma That Has Returned or Does Not Respond to Prior Treatment.

Who this might be right for
Recurrent Classic Hodgkin LymphomaRefractory Classic Hodgkin Lymphoma
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT05137886
What this trial is testing

PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRelapseRefractory Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 47
Testing effectiveness (Phase 2)Study completedNCT02824029
What this trial is testing

Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
Barbara Ann Karmanos Cancer Institute 28
Large-scale testing (Phase 3)UnknownNCT04342936
What this trial is testing

Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03712202
What this trial is testing

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage I Hodgkin LymphomaAnn Arbor Stage I Mixed Cellularity Classic Hodgkin LymphomaAnn Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma+11 more
City of Hope Medical Center 155
Testing effectiveness (Phase 2)UnknownNCT03617666
What this trial is testing

Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study

Who this might be right for
Hodgkin Lymphoma
University College, London 49
Testing effectiveness (Phase 2)Looking for participantsNCT06393361
What this trial is testing

Chidamide Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.

Who this might be right for
Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma
Chinese PLA General Hospital 100
Early research (Phase 1)Ended earlyNCT00023790
What this trial is testing

Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin

Who this might be right for
Breast CancerHead and Neck CancerLymphoma+3 more
Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Testing effectiveness (Phase 2)Study completedNCT02414568
What this trial is testing

Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin

Who this might be right for
Classical Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 90
Testing effectiveness (Phase 2)Study completedNCT00540007
What this trial is testing

Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Disease
Washington University School of Medicine 80
Early research (Phase 1)Active Not RecruitingNCT03212404
What this trial is testing

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell LungCarcinoma, Small Cell+10 more
Checkpoint Therapeutics, Inc. 272
Testing effectiveness (Phase 2)Ended earlyNCT03776864
What this trial is testing

Umbralisib and Pembrolizumab in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
University of Washington 6
Testing effectiveness (Phase 2)UnknownNCT04233294
What this trial is testing

Addition of Chidamide to the Combination Treatment of Decitabine Plus Camrelizumab in Combination Treatment Resistant/Relapsed Patients With Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Chinese PLA General Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Large-scale testing (Phase 3)UnknownNCT04044222
What this trial is testing

Evaluate the Efficacy and Safety of a Sintilimab Plus ICE Regimen Versus ICE Regimen in Classic Hodgkin's Lymphoma Patients (cHL) Who Have Failed First-line Standard Chemotherapy

Who this might be right for
Classic Hodgkin's Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT03652441
What this trial is testing

Consolidation Therapy With Brentuximab Vedotin After Allogeneic Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Cologne 14
Not applicableStudy completedNCT01459224
What this trial is testing

MELT - MRI Evaluation of Lymphoma Treatment

Who this might be right for
Lymphoma, Hodgkin
University College, London 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT03749018
What this trial is testing

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnn Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell LymphomaAnn Arbor Stage II B-Cell Non-Hodgkin Lymphoma+11 more
David Bond, MD 30
Next Page